Global Lancets Market Size Study & Forecast, by Type (Safety Lancets [Manually & Pressure Activated], Standard Lancets), by Application (Glucose Testing, Cholesterol Testing), by Gauge Size (22G and Below), by Age Group (Adult, Pediatrics), by End Users (

The Global Lancets Market, valued at approximately USD 2.53 billion in 2024, is poised to escalate at a compelling CAGR of 9.70% from 2025 to 2035, fueled by surging prevalence of chronic ailments such as diabetes, the rising adoption of self-monitoring devices, and heightened healthcare awareness worldwide. Lancets, small medical implements designed for capillary blood sampling, have evolved from simple, single-use needles to technologically advanced, safety-engineered devices that mitigate the risk of needlestick injuries and cross-contamination. As the healthcare ecosystem undergoes a transformative shift towards patient-centric models, lancets are increasingly being integrated into at-home diagnostic kits, enabling individuals to take greater control over their health data and treatment plans.

The mounting global incidence of diabetes, coupled with lifestyle-related disorders, has significantly amplified the demand for lancets, particularly in glucose testing applications. According to the International Diabetes Federation, over 540 million adults were living with diabetes in 2021, a figure projected to exceed 780 million by 2045. These alarming trends have intensified efforts toward regular monitoring, driving substantial growth for both safety and standard lancets. Technological innovations—such as adjustable penetration depths, painless pricking mechanisms, and ergonomic designs—are enabling manufacturers to cater to diverse patient demographics, from pediatric to geriatric populations. However, the market’s momentum could face headwinds from increasing penetration of non-invasive glucose monitoring technologies, which, while still in nascent stages, present a potential long-term substitute for traditional lancets.

Regionally, North America currently holds the lion’s share of the global market, underpinned by advanced healthcare infrastructure, high diabetes prevalence, and widespread adoption of point-of-care diagnostics. The U.S. continues to lead with its robust network of diagnostic centers and proactive patient monitoring initiatives. Europe follows closely, benefiting from favorable reimbursement policies and strong public health programs. In contrast, the Asia Pacific region is projected to witness the most accelerated growth through 2035, propelled by a burgeoning diabetic population, expanding healthcare access in emerging economies like India and China, and growing government initiatives promoting early disease detection. Meanwhile, the Middle East & Africa and Latin America are gradually emerging as lucrative markets, driven by rising healthcare spending, increasing urbanization, and growing awareness of preventative healthcare practices.

Major market players included in this report are:
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Terumo Corporation
• Owen Mumford Ltd.
• HTL-STREFA S.A.
• Medtronic plc
• Ypsomed Holding AG
• ARKRAY, Inc.
• Greiner Bio-One International GmbH
• Apexmed International BV
• Nipro Medical Corporation
• Cambridge Sensors Ltd.
• Braun Melsungen AG
• LifeScan, Inc.

Global Lancets Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• Safety Lancets (Manually Activated, Pressure Activated)
• Standard Lancets

By Application:
• Glucose Testing
• Cholesterol Testing

By Gauge Size:
• 22G and Below

By Age Group:
• Adult
• Pediatrics

By End Users:
• Hospitals

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more